This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA Peptide Reclassification 2026: What Researchers Want FDA Vs. Minnesota Law: Where Peptide Compliance Actually Breaks Down Holt Law FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026)